Avedro, Inc. Company Profile

09:31 EST 20th February 2019 | BioPortfolio

Avedro, a privately held medical device company based in Waltham, MA, is developing the science of Thermo-biomechanics for therapeutic medical applications. Keraflex® KXL is the first technology Avedro has developed from its Thermo-biomechanics platform. Avedro recently announced it has signed a definitive agreement with Peschke Meditrade GmbH to acquire the rights to its US-based Phase III studies of corneal collagen crosslinking for the treatment of progressive keratoconus and post LASIK ectasia. The company looks forward to closing the follow-up phase of the studies and completing the necessary steps to introduce crosslinking to the US market.

News Articles [9 Associated News Articles listed on BioPortfolio]

Avedro looks to launch $86M public offering

A prospectus has been filed by Avedro for an initial public offering in hopes of raising $86 million. -More- 

Ophthalmic device company Avedro plans $75M IPO

Ophthalmic medical systems company Avedro will offer 5 million shares at $14 to $16 each in hopes of raising $75 million in i -More- 

Avedro Starts U.S. IPO Effort

IPO Update: Avedro Files Proposed Terms For IPO

Avedro IPO: Speculative, But With An Ongoing Phase 3 Clinical Trial

Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations

J Code 2787, Effective January 1, 2019, Expected to Streamline Reimbursement and Expand Patient Access Avedro, Inc., a leading commercial-stage ophthalmic med...

Anthem Blue Cross Blue Shield Joins List of 60 Commercial Plans Covering Avedro’s FDA-Approved Corneal Cross-Linking Procedure

Cross-linking now covered by the top five largest commercial insurance companies Avedro, Inc., a leading commercial-stage ophthalmic medical technology company a...

Cigna Is Newest Payer to Join Growing List of Commercial Plans Covering Avedro’s FDA-Approved Cross-Linking Procedure—133 Million Lives Covered in Total

Avedro Names Tim Homer Vice President of Health Policy & Market Access in Continued Effort to Expand Market Access and Reimbursement of Cross-Linking Avedro, ...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Photrexa viscous [avedro, inc.]

These highlights do not include all the information needed to use PHOTREXA VISCOUS and PHOTREXA safely and effectively. See full prescribing information for PHOTREXA VISCOUS and PHOTREXA. PHOTREXA VIS...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Corneal Cross-Linking: Current USA Status: Report From the Cornea Society.

The initial published clinical report on riboflavin/ultraviolet A corneal cross-linking (CXL) for treatment of progressive keratoconus dates back to 2003. CXL has since then been widely used outside t...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking

Corneal ectasia is characterized by irregularity and thinning of the cornea, causing the cornea to bulge forward and cause distorted vision and impaired visual acuity. Corneal ectasia is a...

Companies [2 Associated Companies listed on BioPortfolio]

Avedro, Inc.

Avedro, a privately held medical device company based in Waltham, MA, is developing the science of Thermo-biomechanics for therapeutic medical applications. Keraflex® KXL is th...

Avedro Inc.

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking and refractive correction. Avedro’s product...

More Information about "Avedro, Inc." on BioPortfolio

We have published hundreds of Avedro, Inc. news stories on BioPortfolio along with dozens of Avedro, Inc. Clinical Trials and PubMed Articles about Avedro, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avedro, Inc. Companies in our database. You can also find out about relevant Avedro, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record